Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
Status:
Completed
Trial end date:
2010-07-15
Target enrollment:
Participant gender:
Summary
This study will investigate whether the plasma concentration-time profile and
pharmacokinetics (PK) of suvorexant (MK-4305) in participants with impaired renal function
are similar to those observed in healthy participants; and will evaluate the safety and
tolerability of suvorexant both in participants with impaired renal function and in healthy
participants.